Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is conducting a market survey to determine the availability and technical capability of qualified small businesses, including 8(a) small businesses, small disadvantaged businesses, woman-owned small businesses, service-disabled veteran-owned small businesses or HUBZone small businesses capable of processing DNA using a new high-density gene microarray to define the genotype of individual mice at many loci throughout the genome. The Mouse Universal Genotyping Array (MUGA) provides 7,851 single nucleotide polymorphism (SNP) markers (built on the Illumina Infinium platform). The MUGA design criteria makes it optimal for detecting heterozygous regions and discriminating between haplotypes in homozygous regions. The array's allele frequencies and haplotypes were derived from eight laboratory mouse strains (A/J, C57BL/6J, 129S1/SvImJ, NOD/LtJ, NZO/HlLtJ, CAST/EiJ, PWK/PhJ, and WSB/EiJ).

Interested firms with the capability of providing, at a minimum, fifty-one percent (51%) of the required service, shall submit a capability statement to assist the Government in determining in accordance with Federal Acquisition Regulation (FAR) 19.502-2(b)whether or not this procurement will be set-aside for any of the programs described above. The intended procurement will be classified under North American Industrial Classification (NAICS) code 541380 with a size standard of $14.0M. All respondents are requested to identify their firm's size and type of business. Interested firms responding to this market survey must provide a capability statement demonstrating their experience, skills and capability to fulfill the Government's requirements for the above. The capability statement shall be in sufficient enough detail, but not to exceed ten (10) pages, so that the Government can determine the experience and capability of your firm to provide the requirements above. Your capability statement should include a minimum of three references. Two (2) copies of the capability statement must be received at the contracting office address: 6100 Executive Blvd, Room 5Z00, Rockville, MD 20852 - ATTN: Tracey Muck, prior to 3:00 p.m. eastern standard time on June 20, 2012. Email and fax submission of capability statements will not be accepted. Capability statement must reference solicitation# NIH-NICHD-12-049. Any questions must be sent via email to [email protected] and must include solicitation # NIH-NICHD-12-049 in the subject line of email. Capability statements, etc will not be returned to firm/sender. This synopsis is for information and planning purposes and is not to be construed as a commitment by the government, nor will the government pay for information solicited.

Bid Protests Not Available